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The primary objective of characterizing bovine adenovirus type 3 (BAV3) in greater detail is to develop it as a vector for
gene therapy and vaccination of humans and animals. A series of BAV3 early region 4 (E4) deletion-mutant viruses, containing
deletions in individual E4 open reading frames (Orf) or combinations of Orfs, were generated by transfecting primary fetal
bovine retinal cells with E4-modified genomic DNA. Each of these mutants was further analyzed for growth kinetics, viral DNA
accumulation, and early/late protein synthesis. Mutant viruses carrying deletions in Orf1, Orf2, Orf3, or Orf4 showed growth
characteristics similar to those of the E3-deleted BAV3 (BAV302). DNA accumulation and early/late protein synthesis were
also indistinguishable from those of BAV302. However, mutant viruses carrying a deletion in Orf5, Orfs 1–3 (BAV429), or Orfs
3–5 (BAV430) were modestly compromised in their ability to grow in bovine cells and express early/late proteins. E4 mutants
containing larger deletions, Orfs 1–3 (BAV429) and Orfs 3–5 (BAV430), were further tested in a cotton rat model. Both mutants
replicated as efficiently as BAV3 or BAV302 in the lungs of cotton rats. BAV3-specific IgA and IgG responses were detected
in serum and at the mucosal surfaces in cotton rats inoculated with mutant viruses. In vitro and in vivo characterization of
these E4 mutants suggests that none of the individual E4 Orfs are essential for viral replication. Moreover, successful
deletion of a 1.5-kb fragment in the BAV3 E4 region increased the available insertion capacity of replication-competent BAV3
vector (E3–E4 deleted) to ;4.5 kb and that of replication-defective BAV3 vector (E1a–E3–E4 deleted) to ;5.0 kb. This is
extremely useful for the construction of BAV3 vectors that express multiple genes and/or regulatory elements for gene
therapy and vaccination. © 2001 Academic Press
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Adenovirus gene expression can be divided into early
and late phases, which are separated by the onset of
viral DNA replication (Persson and Philipson, 1982). As in
human adenoviruses (HAV), bovine adenovirus type 3
(BAV3) contains early genes E1, E2, E3, and E4 that are
transcribed from individual promoters and are located on
both strands (Baxi et al., 1999; Idamakanti et al., 1999;
Reddy et al., 1999a). In contrast, late genes are gener-
ated by alternative splicing of a single polycistronic
mRNA transcribed from a single promoter, the major late
promoter. In BAV3, late mRNAs can be divided into seven
families (L1 to L7) compared to five in HAVs (Reddy et al.,
1998). In general, the early genes function in the regula-
tion of viral transcription, transformation, and viral DNA
replication, while the late genes code for structural pro-
teins.
The adenovirus early region 4 (E4) of HAV constitutes
;10% of the viral genome and genetic analysis has
demonstrated that some of the E4 products are essential
for virus infection (reviewed by Leppard, 1997). A com-
plex set of phenotypes has been demonstrated by dele-
tion analysis of E4, showing that E4 products play vital
1 This is VIDO Journal Article No. 301.
t
t
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (306) 966-7478. E-mail: Tikoo@sask.usask.ca.
153roles in virus infection. E4 proteins are involved at sev-
eral levels of regulation of cellular and viral gene expres-
sion, viral DNA replication, late viral assembly, E2 ex-
pression, and adeno-associated virus helper function
(Halbert et al., 1985; Huang and Hearing, 1989; Richard-
son and Westphal, 1981; Weinberg and Ketner, 1986).
Several sets of differentially spliced mRNAs are gener-
ated from the E4 region during viral infection (Dix and
Leppard, 1993; Freyer et al., 1984; Tigges and Raskas,
984; Virtanen et al., 1984). Of the possible seven open
eading frames (Orf) encoded by the E4 region of HAV,
rf3 or Orf6 is absolutely essential for viral growth in
issue culture (Bridge and Ketner, 1989; Huang and Hear-
ng, 1989; Ketner et al., 1989). Both proteins increase viral
ate protein production by facilitating the accumulation of
RNAs at a posttranscriptional level. E4 Orf6 forms a
hysical and functional complex with E1B-55kDa (Bridge
nd Ketner, 1990; Rubenwolf et al., 1997) and helps it to
arget the 55k protein to the nucleus (Ornelles and
henk, 1991). It has also been suggested that this E4
rf6–55k complex shuttles between the two cellular
ompartments and serves as a nucleocytoplasmic trans-
orter of viral mRNAs (Dobbelstein et al., 1997; Weigel
nd Dobbelstein, 2000) and also inhibits the export of
ost cellular mRNAs (Babiss et al., 1985). E4 Orf6 also
as a direct effect on transactivation of p53 by forming a
ertiary complex between p53, E4 Orf6, and 55k, leading
o degradation of p53 (Boivin et al., 1999; Boyer and
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154 BAXI ET AL.Ketner, 2000; Cathomen and Weitzman, 2000). The E4
Orf6 can also block p53-dependent apoptosis (Moore et
al., 1996) and can cooperate with E1A to transform pri-
ary rodent cells (Moore et al., 1996; Nevels et al., 1997).
4 Orf3 appears to relieve the E1B inactivation of p53
ndependently and plays a role in relocating sites of
eplication and transcription in the nucleus (Leppard and
verett, 1999).
BAV3, a representative of subgroup I of BAVs, has
een shown to replicate in cattle, producing mild or no
linical symptoms (Darbyshire et al., 1965). The complete
enome of BAV3 has been sequenced (Baxi et al., 1998;
Lee et al., 1998; Reddy et al., 1998) and E1, E3, and E4
regions (Baxi et al., 1999; Idamakanti et al., 1999; Reddy
et al., 1999a) have been characterized at the transcrip-
tional level. It has also been demonstrated that the E3
region of BAV3 is not essential for viral replication (Zak-
hartchouk et al., 1998) and vaccine antigens expressed
in the E3 region can induce protective mucosal and
systemic immune responses (Baxi et al., 2000; Zakhart-
chouk et al., 1999). The BAV3 E1A region is essential for
viral replication and E1A-deleted virus can be generated
only in bovine cell lines expressing HAV5 E1 (Reddy et
al., 1999b). We are characterizing BAV3 with the aim of
developing it as the vector of choice for human gene
therapy and vaccination in human and animals.
Early region 4 of BAV3 is located at the extreme right
end of the BAV3 genome from map unit 98.6 to 89.9 (Lee
et al., 1998). The entire BAV3 E4 transcriptional unit is
3004 bp in size and transcribes seven distinct 59–39
coterminal mRNAs, which have potential to encode five
different polypeptides (Baxi et al., 1999). Although pro-
teins encoded by Orf3 and Orf5 of BAV3 E4 show partial
homology to the 34-kDa protein of HAV2 E4 region and its
homologs, the conserved motif HCHXXPGSLQ present in
the 34-kDa protein of HAV2 (Virtanen et al., 1984), the
30.8-kDa protein of OAV287 (Vrati et al., 1996), and the
a/b Orf of MAV1 (Kring et al., 1992) is present only in
BAV3 E4 Orf5. Since no homologs were observed in
other adenoviruses, Orfs 1, 2, and 4 appear to be unique
to BAV3.
In this report, we describe the construction and char-
acterization of BAV3 E4 deletion mutants, both in vitro
and in vivo, with the aim of further analyzing the BAV3 E4
region in detail and increasing the insertion capacity of
BAV3 vector by deleting the nonessential E4 region.
RESULTS
Construction and analysis of E4 mutants
Studies done in HAV E4 suggest that multiple gene
products encoded by E4 share redundant properties. In
order to study functions for gene products encoded by
BAV3 E4, we constructed a series of E4 mutant viruses.Initially, each of the Orfs were serially deleted, followed
by larger deletions by combining the individual E4 Orfs
(Fig. 1). All the mutant viruses were generated by trans-
fecting fetal bovine retina cells (FBRC) with individual
full-length plasmid DNA containing the various E4 dele-
tions. Mutant BAV419 contains a deletion of 143 bp that
disrupts Orf1 with the insertion of an EcoRV linker. Mu-
tant BAV401 contains a deletion of 58 bp that disrupts
Orf2 with the insertion of a SrfI linker. Mutant BAV427
contains a deletion of 172 bp, disrupting Orf3, and has a
SrfI linker inserted. BAV411 and BAV412 contain deletions
of 38 and 78 bp, respectively, disrupting the Orf4 and Orf5
genes, and have a SrfI linker. In order to disrupt Orf3 and
Orf5 simultaneously mutant BAV415, which contains a
total deletion of 250 bp, was generated. Two larger de-
letions were created in the E4 region of BAV3 in order to
identify the regions essential for viral replication. Mutant
BAV429 contains a deletion of 1501 bp and disrupts Orfs
1, 2, and 3 and contains a SrfI linker. BAV430 mutant
disrupts Orfs 3, 4, and 5 and contains a deletion of 1342
bp and a SrfI linker. The various deletions completely
disrupt the Orfs with the exception of mutant BAV411, in
which Orf4 contains internal deletion. However, mutant
BAV430 contains a deletion from Orf3 to 5 that com-
pletely disrupts Orf4. Surprisingly, we were unable to
generate BAV3 mutant virus completely devoid of the E4
region. All the mutant viruses constructed have an E3
deletion (1.245 kb; Zakhartchouk et al., 1998) in the back-
ground.
In order to confirm the presence of the specific muta-
tions/deletions, two different approaches were used: first
the viral DNA was isolated and digested with unique
restriction enzymes. Viral DNA from BAV419 was di-
gested with restriction enzyme EcoRV. Two bands were
observed upon digestion of BAV302 (E3-deleted virus)
viral DNA with EcoRV, since only one EcoRV site is
present in BAV302 (Fig. 2). However, BAV419 has an
additional EcoRV site because of the insertion of the
EcoRV linker, hence we observe three bands upon di-
gestion of BAV419 DNA with EcoRV (Fig. 2). Viral DNA
from BAV401, BAV427, BAV411, BAV412, BAV415, BAV429,
and BAV430 was digested with Srf I. All these mutant
viruses show an additional band compared to BAV302
(only one Srf I site in BAV302 DNA; Fig. 2), because of the
insertion of the Srf I linker in all of these mutant viral
genomes. Second, the identity of the mutant was con-
firmed by PCR analysis. Primers were generated from
the flanking regions of the deletions (Table 1). Mutant
viral DNAs were PCR amplified and observed for a shift
in the size of their products, generated due to deletions
in the mutants, compared to BAV3 DNA. The results of
the PCR analyses are summarized in Fig. 3 and Table 1.
Compared to the BAV3 control, all the deletion mutants
yielded the expected smaller amplification products.
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155EARLY REGION 4 OF BOVINE ADENOVIRUS TYPE 3In vitro characterization of BAV3 E4 mutants
Virus replication in vitro. In order to determine whether
single Orf deletion or larger deletions had a noticeable
ffect on the ability of BAV3 to replicate in vitro, growth
kinetics of the individual E4 mutant viruses were ana-
lyzed in MDBK cells (Fig. 4). Cultures of MDBK cells were
infected with mutant viruses and cells harvested at 6, 12,
24, 36, 48, and 72 h postinfection. Virus from each sam-
ple was released by freeze–thawing and titered on
MDBK cells. Mutant viruses with deletions in Orf1, Orf2,
Orf3, and Orf4 grew with comparable efficiencies com-
pared to BAV302 (E3-deleted) virus. However, the mutant
viruses that have deletions in Orf5 and Orfs 3 and 5 and
mutant viruses that have a larger deletion, Orf1–3 and
Orf3–5, showed slower growth characteristics compared
FIG. 1. E4 transcription map and mutant viruses. The right end of BA
epresented at the top. Some of the unique features of the E4 region, s
tart), right inverted terminal repeat (ITR), and poly(A), are also illustra
howing the direction of transcription. Relevant restriction endonucleas
lso marked. Each of E4 deletion mutants described in the text are illu
reated in each of E4 mutants.to BAV302. These mutant viruses (BAV412, BAV415,
BAV429, and BAV430) produced 2–3 logs less virus com-
s
cpared to BAV302 at 24, 36, and 48 h postinfection. How-
ever, the final yields of these viruses were within 1 log
compared to that of BAV302.
Viral DNA replication. Viral DNA replication was as-
sayed at various times postinfection of MDBK cells with
the BAV302 or mutant viruses. Viral DNA was isolated at
24, 36, and 48 h after infection, and viral DNA accumu-
lation was measured by dot blot analysis using 32P-
labeled adenovirus genomic DNA as a probe (Fig. 5). The
levels of viral DNA at 24 h after infection were compa-
rable among various mutant viruses to that observed in
the BAV302 virus. However, at 36 and 48 h postinfection,
a lag in the onset of viral DNA replication was observed
specifically in the viruses that carry larger deletions.
Based on densitometric analysis (n 5 3) there was a
ome (30,833–34,446 nucleotides, as determined by Lee et al., 1998) is
internal repeats (IR1 and IR2), TATA box, E4 transcription start site (T.
e predicted five open reading frames are indicated by shaded arrows
age sites that are used in the construction of E4 deletion mutants are
individually, with the solid black bars corresponding to the deletionsV3 gen
uch as
ted. Th
e cleavignificant two- to three-fold reduction of viral DNA ac-
umulation compared to BAV302 at 36 and 48 h postin-
to
pon dig
156 BAXI ET AL.fection but not at 24 h. The mutant viruses that have only
one Orf disrupted accumulated viral DNA with similar
kinetics compared to the BAV302 virus.
Viral early and late protein synthesis. In order to study
he effect of the deletion on viral protein synthesis, MDBK
FIG. 2. Restriction enzyme analysis of the mutant viruses. MDBK ce
f the mutant viruses. The DNA from mutant BAV419 was digested with E
BAV429, and BAV430 was digested with SrfI. BAV302 DNA was digeste
sizing the DNA fragments. Expected DNA fragment sizes generated u
individual mutant viruses.
T
PCR Analysis of th
Virus Primers
BAV419 59TTCACTTGCGGCAGCTC39
59TCAACGATGAGGACCAGCTGA39
BAV402 59ATTCTTGGCACAGTCTTCG39
59CAATCCAGTGGTCTCTC39
BAV427 59CAATTCCGACAGCTGAG39
59CATCGACTAGCAGACAC39
BAV411 59TATGGTGGACCAAGTGC39
59CAACTAGTCAAGTGAGCGTCCT39
BAV412 59CACTATGATTCACGGCCCATTCC39
59GACAAGTCATACCGGTC39
BAV415 59CAATTCCGACAGCTGAG39
59GACAAGTCATACCGGTC39
BAV429 59CATTGTTCCGTGTTCTGC39
59CATCGACTAGCAGACAC39
BAV430 59CAATTCCGACAGCTGAG39
59GACAAGTCATACCGGTC39cells were infected with BAV302 or mutant viruses and
labeled with [35S]-methionine. Proteins from cellular ly-
sates were immunoprecipitated with rabbit polyclonal
antibodies specific for BAV3 early region 1B small
(E1Bsmall), DNA binding protein (DBP), or fiber and ana-
infected with various mutants and viral DNA was extracted for each
nd DNA from mutant viruses BAV401, BAV427, BAV411, BAV412, BAV415,
EcoRV and SrfI as a control. A 1 kb DNA ladder (lane M) was used for
estion with unique restriction enzymes are shown below each of the
E4 Recombinants
eleted
Expected size
in BAV3 (bp)
Expected size
in recombinants (bp)
456 311
392 334
590 418
435 397
648 570
and 5 1835 1585
3 1892 391
5 1835 493lls were
coRV a
d withABLE 1
e BAV3
Orf d
Orf1
Orf2
Orf3
Orf4
Orf5
Orf3
Orf1–
Orf3–
oc region
b Molecu
157EARLY REGION 4 OF BOVINE ADENOVIRUS TYPE 3lyzed by SDS–polyacrylamide gel electrophoresis (PAGE)
(Fig. 6). Densitometric analysis of early protein produc-
tion by BAV302 and mutant viruses suggests that mutant
viruses expressed similar or higher amounts of E1Bsmall
and DBP protein compared to BAV302 (Figs. 6a and 6b).
However, the amount of viral late protein synthesis as
observed by fiber production was reduced in all the
mutants compared to BAV302, with the exception of
BAV430 (Fig. 6c).
In vivo characterization of BAV3 E4 mutants
Virus replication in respiratory tract of cotton rats. In
rder to determine whether E4 deletions have any effect
FIG. 3. Genomic PCR of the viral mutants. PCR-amplified product
omparison to PCR products generated by amplification of the similar
y PCR from BAV3 and mutant viruses are also shown at the bottom.
FIG. 4. Growth kinetics of the E4 mutant viruses. Confluent mono-
layers of MDBK cells were infected at m.o.i. of 0.1 with BAV302 (E3
deleted) and mutant viruses. Infected MDBK cells were harvested at
the indicated times postinfection, and the amounts of virus in cell
lysates were determined by plaque assay and represented as plaque-
forming units/ml.on kinetics of virus replication and clearance from the
lungs of inoculated cotton rats, titers of infectious virus
recovered from the lungs of animals inoculated with
either BAV429 or BAV430 were compared with that of
BAV302 and wild-type BAV3. Following intranasal inocu-
lation of cotton rats with 107 pfu of recombinant viruses,
there was a decline in virus titers in all four groups at day
2 p.i., followed by 1 log increase in virus titers on day
3 p.i. (Fig. 7). This increase in the amount of virus titer
might be a result of active virus replication. There was a
rated by primers flanking the individual E4 deletions are shown in
from BAV3 DNA. The expected sizes of amplified products generated
lar size markers are indicated on the left.
FIG. 5. DNA replication assay. Total viral DNA was isolated from
MDBK cells that were infected with BAV302 and mutant viruses at m.o.i.
of 10. The DNA was isolated at various time points, denatured, neu-
tralized, and diluted as indicated and transferred onto the nitrocellulose
membrane by using the dot-blot apparatus. The blot was hybridizeds genewith 32P-labeled BAV3 genomic probe. The hybridized DNA was visu-
alized by autoradiograph.
M
v
immunoprecipitated with (a) E1Bsmall, (b) DBP, or (c) fiber polyclonal
antibody and analyzed by 10% SDS–PAGE. Specific bands of 19, 48, and
t
t
B
r
158 BAXI ET AL.4–5 log decline in virus titer on day 6 p.i. Over the 6-day
period, the amounts of infectious virus shed by both
mutant viruses were similar to those recovered from
lungs of BAV302- and BAV3-inoculated cotton rats (Fig. 7).
Immune response against mutant viruses in cotton
rats. In order to study the immune response generated
by deletion mutants, cotton rats were inoculated intrana-
sally at 0 and 3 weeks with BAV3, BAV302, BAV429, and
BAV430 viruses. The serum samples were collected at 3
and 6 weeks, and nasal and lung washes were collected
at 6 weeks after primary infection. The sera were tested
for BAV3-specific IgG response by ELISA (Fig. 8a). At 3
weeks p.i., all the viruses generated similar BAV3-spe-
cific IgG antibodies, which were further boosted three- to
four-fold following a second inoculation. However, no
significant differences were seen among the four groups
(P , 0.5). The nasal and lung washes collected from
BAV3- and mutant-infected cotton rats were tested for
BAV3-specific IgA antibodies by ELISA. Cotton rats im-
munized with BAV429 and BAV430 mutant viruses
showed similar IgA titers compared to those animals
infected with BAV3 and BAV302 (Fig. 8b).
DISCUSSION
The work described in this article was undertaken
primarily to further characterize the BAV3 E4 region. In
order to delineate the function of BAV3 E4 gene products
in viral replication we constructed a series of mutant
102 kDa were observed for E1Bsmall, DBP, and fiber proteins, respec-
ively, under reducing conditions. Results of densitometric scanning of
he E1Bsmall, DBP, or fiber immunoprecipitations are also shown below
each immunoprecipitation as mean values for triplicate samples 6SD.
FIG. 7. Virus replication in the lungs of cotton rats. Animals were
inoculated intranasally with 107 pfu of BAV3, BAV302, BAV429, or
AV430 and lungs were collected at days 2, 3, and 6. Each time point
epresents mean virus titers for three animals 6 SD.FIG. 6. Viral early and late protein synthesis. Confluent monolayers of
DBK cells were either mock infected or infected with BAV302 and
arious mutant viruses at m.o.i. of 10 and labeled with [35S]methionine.
At 24 h postinfection, proteins from lysates of radiolabeled cells wereThe expression of proteins in BAV302 is taken as 100%, with other
results expressed relative to it.
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159EARLY REGION 4 OF BOVINE ADENOVIRUS TYPE 3viruses that contain deletions in individual or multiple
Orfs of BAV3 E4. Eight mutant viruses were generated
following transfection of FBRC cells with DNA containing
the various deletions. Studies carried out in the HAV5 E4
region suggest that this region encodes one or more
functions which are required for lytic growth in cell cul-
ture, as was demonstrated by the defective phenotype of
the virus in which the complete E4 was deleted (Halbert
et al., 1985; Huang and Hearing, 1989; Krougliak and
raham, 1995; Weinberg and Ketner, 1986). However,
AV5 E4 Orfs 3 and 6 have been shown individually to
rovide the E4 function necessary for normal viral DNA
eplication in the absence of other E4 products (Bridge
nd Ketner, 1989). Thus, E4 Orf3 and Orf6 can partially or
otally compensate for each others’ deficiencies and the
resence of one these Orfs is essential for HAV5 repli-
ation. In BAV3 E4, the sequential deletions of the indi-
idual Orfs (Orf 1 to 5) suggest that none of the individual
rf appears to be absolutely necessary for virus replica-
ion. BAV3 E4 Orf3 and Orf5 show partial homology to
AV5 E4 Orf6; however, simultaneous deletion of Orfs 3
nd 5 resulted in the generation of a viable mutant virus,
AV415. This suggests that unlike HAV5 E4 Orf6, BAV3 E4
rf3/Orf5 do not encode a gene function necessary for
iral DNA replication and no functional interaction/com-
FIG. 8. Antibody response in cotton rats immunized intranasally with
BAV3, BAV302, BAV429, and BAV430. (a) BAV3-specific IgG ELISA titers
in serum on days 21 and 42 p.i. (b) BAV3-specific IgA ELISA titers in
nasal and lung washes on day 42 p.i.ensation exists between the gene products of BAV3 E4
rfs 3 and 5. This hypothesis was further supported bythe successful rescue of mutant virus BAV430, containing
deletion of Orf 3 to 5. Also the complete disruption of Orfs
1, 2, and 3 in mutant virus BAV429 suggests that none of
the Orfs are essential for virus replication singly or as a
complex.
All eight BAV3 E4 mutant viruses were further charac-
terized in terms of growth characteristics, DNA replica-
tion, and early/late protein synthesis. None of the E4
mutant viruses appears to be severely defective in their
growth, as they were easily propagated on normal MDBK
cells. However, based upon their growth characteristics
these mutant viruses can be grouped into two classes
(I and II; Fig. 4). Mutant viruses in class I have single
deletions in individual Orfs from Orf1 to 4 and exhibited
growth characteristics similar to those of BAV302. This
suggests that single deletions do not have any marked
effect on virus propagation. Moreover, disruption of the
function of one polypeptide might be substituted by an-
other polypeptide. Mutant viruses in class II either have
deletion in Orf5 or contain a larger deletion which dis-
rupts at least three Orfs. These mutant viruses exhibit
slower growth characteristics compared to BAV302. The
larger deletions and disruption of Orf5 appear to partially
inhibit the growth of these recombinant viruses. Similarly,
HAV5 E4 mutants have been grouped into three classes
(Huang and Hearing, 1989), group III being severely de-
fective for virus growth since they lack both Orf3 and Orf6
gene products. However, no such distinct group was
evident in BAV3 E4 mutants that showed severe growth
defects. Upon analysis of viral DNA replication, none of
mutants carrying a disruption in a single Orf appear to be
defective in viral DNA accumulation. However, mutants
BAV429 and BAV430, carrying larger deletions, do show
a DNA synthesis defect. Both these viruses appear to
accumulate lesser amounts of viral DNA at 24, 36, and
48 h compared to BAV302. These observations appear to
be consistent with the results obtained in single-step
growth curves of these viruses, in which a lag in growth
is visible at these time points. However, severe DNA
accumulation defects were observed in completely E4-
deleted HAV mutants (H2dl808, Weinberg and Ketner,
1986; H2dl366, Halbert et al., 1985).
We next analyzed the viral early (E1Bsmall and DBP) and
late (fiber) production of the E4 mutant viruses. There
appears to be no severe defect on production of E1 and
E2 early proteins by any of the mutant viruses. Some of
the BAV3 E4 mutants appear to rather overproduce these
early proteins, an observation similar to one seen with
HAV E4 mutants that overexpress E2 72K DBP protein
(Halbert et al., 1985; Hemstrom et al., 1988). However,
deletions in the BAV3 E4 region do appear to partially
inhibit fiber production in these mutant viruses with the
exception of BAV430, from which the amount of fiber
produced is similar to that of BAV302. This observation
does support the conclusions drawn from HAV studies
(Weinberg and Ketner, 1986; Bridge and Ketner, 1989) that
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160 BAXI ET AL.late protein production is independent of viral DNA ac-
cumulation in infected cells.
BAV3 E4 mutants BAV429 and BAV430, which showed
a partial defect in virus growth, DNA replication, and
early/late protein production in vitro, were further char-
acterized in vivo by infecting cotton rats intranasally. Both
E4 mutant viruses replicated as efficiently was wild-type
BAV3 and BAV302 in the lungs of cotton rats, suggesting
that these deletions have little effect if any on virus
replication in vivo. Both deletion mutants were also able
to generate similar BAV3-specific IgG and IgA responses
in serum and mucosal surfaces of cotton rats compared
to BAV3 and BAV302. These results suggest that larger
deletions seem to have no effect on mutant BAV429 and
BAV430 phenotypes in vivo, despite the fact that some
phenotypic defects were observed in vitro.
Our initial attempts to rescue virus completely devoid
of BAV3 E4 by transfecting FBRC cells have not been
successful. One of the reasons could be the highly un-
stable nature of the region in-between BAV3 E4 and the
right inverted terminal repeat (ITR). Occasionally, recom-
binant viruses containing multiple repeat insertions of
approximately 500 bp have been identified in-between
the TATA box of BAV3 E4 and the right ITR. Similar
observations have also been made in the Manhattan
strain of CAV2, in which the presence of at least 23
repeats of ;120 to 150 bp in the right ITR resulted in
generation of unstable CAV2 virus (Fejer et al., 1992).
Another reason might be that complete deletion of BAV3
E4 brings the right ITR in close proximity to the L7 region,
which might cause destabilization of the L7 message.
The destabilization of the BAV3 L7 region might be due to
the spacing between the L7 and the E4 regions, the
improper termination of L7 message, or the generation of
antisense L7 RNA from the E4 transcripts. Similar studies
in HAV showed that when E4 was completely deleted
there was a reduction in the accumulation of the late
protein fiber (Brough et al., 1996). Further studies are
needed to prove or disprove these suggestions.
The primary objective of characterizing BAV3 in
greater detail is to use BAV3 for human gene therapy and
vaccination of humans and animals. In order to accom-
modate larger/multiple genes it is necessary to increase
the insertion capacity of the BAV3 vector. The insertion
capacity of available BAV3 vector is 3.0 kb for replication-
competent vectors (deletion in BAV3 E3—1.245-kb dele-
tion; Zakhartchouk et al., 1998) and 3.5 kb for replication-
defective vectors (additional E1a region deletion—541
bp, Reddy et al., 1999b), which is sometimes not suffi-
ient to insert larger genes or multiple genes in order to
roduce multivalent vaccines. The successful deletion of
501 bp in the E4 region (BAV429) increased the avail-
ble insertion capacity of replication-competent BAV3
3–E4 deleted vector and replication-defective BAV3
1a–E3–E4 deleted vector to ;4.5 and ;5.0 kb, respec-
ively. This will help us to develop safer vaccines inhich E1 and E4 have been partially deleted. Moreover,
y using the E1, E3, and E4 regions for transgene place-
ent, a single adenovirus can be used for multitrans-
ene expression. This is extremely important when pro-
ucing cost-effective vaccines, especially in animals, in
hich multiple antigens can be expressed from a single
ector.
In summary, the results of this study suggest that: (i)
ndividual Orfs of the BAV3 E4 can be deleted and thus
re nonessential for viral replication; (ii) larger deletions,
rfs 1–3 and Orfs 3–5, also generated viable viruses that
rew with slightly slower kinetics compared to E3-de-
eted virus; (iii) mutant BAV3 virus with the entire E4
egion deleted could not be rescued; (iv) in vivo charac-
erization of mutant viruses suggests that mutants grow
s efficiently as the wild-type BAV3 in the cotton rat
odel and induce BAV3-specific mucosal and systemic
mmune response; and, finally, (v) the total available
nsertion capacity of E3–E4 deleted and E1a–E3–E4 de-
eted BAV3 vector was increased to ;4.5 and ;5.0 kb.
MATERIALS AND METHODS
Cells and viruses
The WBR-1 strain of BAV-3 was cultivated in MDBK.
MDBK and FBRC were grown in Eagle’s minimum essen-
tial medium (MEM) supplemented with 10% fetal bovine
serum (FBS). A purified preparation of BAV3 and mutant
viruses was obtained following a double cesium chloride
density-gradient centrifugation (Graham and Prevec,
1991). The viral DNA was extracted from virus-infected
monolayers by the method of Hirt (1967).
Antibodies
The production and characterization of BAV3 E1Bsmall-
nd BAV3 DBP-specific antibodies have been described
lsewhere (Reddy et al., 1999a; Zhou et al., 2001). The
ntibodies against E1Bsmall and DBP recognize 19- and
48-kDa proteins, respectively, in BAV3-infected cells. The
antibodies generated against the knob domain of BAV3
fiber recognize a protein of 102 kDa in BAV3-infected
cells (Wu et al., manuscript in preparation).
Construction of recombinant plasmids
The recombinant plasmid vectors were constructed by
standard procedures (Sambrook and Russell, 2001), us-
ing restriction enzymes and other DNA-modifying en-
zymes as described by the manufacturers. In order to
create deletions in the BAV3 E4 region, transfer plasmid
E4polyIISn, described elsewhere (Baxi et al., 1999), was
used. A schematic representation of various E4 deletion
mutants is described in detail in Fig. 1. The deletion in E4
Orf1 was generated by digesting E4polyIISn with ScaI–
MluI (33905–33762 bp on BAV3 genome) and inserting
an EcoRV linker. E4 Orf2 was deleted by digesting
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161EARLY REGION 4 OF BOVINE ADENOVIRUS TYPE 3E4polyIISn with BclI–AflII (33305–33247 bp) and inserting
a Srf I linker. A PstI–HpaI fragment (32576–32404 bp) was
deleted from the E4 Orf3 and a Srf I linker was inserted.
E4 Orf4 was deleted by digesting with SplI–PpuMI
(31744–317606 bp) and inserting a Srf I linker. E4 Orf5
carries a NcoI–XmaI (31680–31530 bp) deletion and has
a Srf I linker inserted in the deletion. In order to generate
Orf1 to 3 deletion, ScaI–HpaI (33905–32404 bp) was
eleted and a Srf I linker was inserted. Digestion of
E4polyIISn with PstI–DraIII (32576–31234 bp) created an
Orf3 to 5 deletion in E4 region and a Srf I linker was
inserted. Full-length plasmids having various deletions in
the E4 region were generated by using the homologous
machinery of Escherichia coli (Chartier et al., 1996).
Transfer plasmids having the deletions in E4polyIISn
were digested with EcoRI–AhdI and homologous recom-
bination was carried out with SwaI-linearized pFBAV302
in E. coli BJ5183 cells to generate the full-length plas-
mids.
Transfection of cells
FBRC cell monolayers in six-well plates were trans-
fected with 2 to 5 mg of various PacI-digested recombi-
nant full-length plasmid DNAs using Lipofectin (Gibco
BRL). Following transfection, cells were maintained in
MEM containing 2% FBS at 37°C for 15–20 days until
cytopathic effects appeared. Cells showing 50% cyto-
pathic effects were harvested and freeze–thawed three
times, and recombinant virus was plaque-purified on
MDBK cells.
Polymerase chain reaction
PCR was carried out to verify the deletions created in
the E4 mutant viruses. MDBK cells were infected with the
various mutant viruses and viral DNA was extracted
according to the method of Hirt (1967). Amplification
products were generated by creating primers in the 59
and 39 flanking regions of the deletion (details of the
primers used are shown in Table 1). The PCR mix con-
tained 20 pmol of each primer, 0.2 mM dNTPs, 1.5 U Taq
olymerase, 1 3 reaction buffer, and the template viral
NA. The PCR was of a standard design with 30 cycles
f denaturation at 94°C for 30 s, annealing at 55°C for 1
in, and extension at 72°C for 2 min. This was preceded
y an initial denaturing step of 94°C for 5 min and
ompleted by a final extension step of 72°C for 10 min.
he amplificates were analyzed by electrophoresis in a
% agarose gel and visualized with ethidium bromide.
mmunoprecipitations
Monolayers of MDBK cells were infected at m.o.i. of 10
f BAV302 or mutant viruses. After 90 min of absorption,
ells were washed and incubated in MEM containing 2%
BS. At 24 h.p.i., the cells were incubated in glucose-free
ulbuco’s modified Eagle’s medium for 1 h before being
v
alabeled with [35S]methionine (100 mCi/ml). After 12 h of
abeling, cells were washed with PBS and harvested in
adioimmunoprecipitation buffer [RIPA buffer: 150 mM
aCl, 10 mM Tris (pH 7.8), 1% Triton X, 1% sodium
eoxycholate, 0.1% SDS]. Immunoprecipitations were
arried out with polyclonal antibodies against BAV3
1Bsmall, DNA binding protein, and fiber, and complexes
ere captured with protein A–Sepharose beads. Precip-
tates were washed in RIPA buffer and proteins were
eparated by 10% SDS–PAGE. Labeled proteins were
isualized by autoradiography.
iral DNA dot-blot assay
In order to analyze DNA accumulation, MDBK cells
ere infected with BAV302 or mutant viruses at m.o.i. of
0 and total viral DNA was isolated at 24, 36, and 48 h
fter infection. The DNA was denatured in 0.3 N NaOH at
5°C, neutralized with 2 M ammonium acetate (pH 7.0),
iluted 1:10 and 1:100, and transferred onto nitrocellu-
ose by using a dot-blot apparatus. The blots were then
robed by Southern blot hybridization analysis, using
andom-primed 32P-labeled BAV3 DNA. The results were
visualized by autoradiograph.
Animal experiments
A total of 36 6- to 8-week-old cotton rats were divided
into four groups (nine animals/group) and inoculated
intranasally with 107 pfu of purified virus/animal. The four
roups of cotton rats were infected with BAV3, BAV302,
AV429, or BAV430. At 2, 3, and 6 days postinoculation,
nimals were sacrificed with an overdose of halothane
nd the right lungs from inoculated animals were col-
ected in MEM for virus isolation. The left lung was
nflated with and fixed in 10% neutral-buffered formalin
or histopathogical analysis according to the protocol
tandardized by Mittal et al. (1995).
In the second experimental group, 12 cotton rats were
nfected intranasally with 107 pfu purified virus/animal at
and 3 weeks p.i. The cotton rats were divided into four
roups and were infected with BAV3, BAV302, BAV429, or
AV430. At 3 and 6 weeks p.i. blood samples were
ollected to monitor the development of BAV3-specific
ntibodies in ELISA and virus neutralization assay. Nasal
nd lung washes were also collected at 6 weeks p.i. to
etermine mucosal antibody responses against BAV3.
irus isolation
The right lungs were collected from cotton rats inoc-
lated with various viruses and stored at 270°C until
se. Tissues were weighed, homogenized in 1 ml of
EM (Polytron homogenizer; Brinkmann Industries,
exadle, Canada), and centrifuged at 3000 rpm to re-
ove the debris. The resulting supernatant was used forirus titration on MDBK cells and results were expressed
s TCID50/ml.
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The levels of BAV3-specific antibodies in sera, lung,
and nasal washes were determined by ELISA. Immuno-
lon-2 microtiter plates were coated with purified BAV3
(0.1 mg/well) in coating buffer at 4°C overnight. The
lates were washed with PBST between each step. All
amples were serially diluted in PBST-BSA and incu-
ated overnight at 4°C. Antigen-specific IgG was de-
ected by horseradish peroxidase-conjugated goat anti-
at IgG (Cedarlane). Antigen-specific IgA was measured
y rabbit anti-rat IgA, followed by incubation with horse-
adish peroxidase-conjugated goat anti-rabbit IgG. Reac-
ions were visualized with streptavidin–alkaline phos-
hate conjugate and BCIP/NBT.
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